Ashley V DiMarco

2PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 03, 2025
RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy.

Ashley V DiMarco, Mirunalini Ravichandran, Jeff Lau

|May 05, 2025
APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer.

Nina Marie G Garcia, Jessica N Becerra, Sharan Srinivasan

Pageof 1

Frequent Collaborators

1 joint publications

Nina Marie G Garcia

1 joint publications

Jessica N Becerra

1 joint publications

Sharan Srinivasan

1 joint publications

Brock J McKinney

1 joint publications

Feinan Wu

1 joint publications

Matthew Fitzgibbon

1 joint publications

James V Alvarez

1 joint publications

Mirunalini Ravichandran

1 joint publications

Jeff Lau

1 joint publications

Anthony Lima

Frequent Collaborators

1 joint publications

Nina Marie G Garcia

1 joint publications

Jessica N Becerra

1 joint publications

Sharan Srinivasan

1 joint publications

Brock J McKinney

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
See more related videos